Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Tysabri prescribing information
Epstein-Barr virus: an important vaccine target for cancer prevention.
Infection of autoreactive B lymphocytes with EBV, causing chronic autoimmune diseases.
Smoked cannabis for spasticity in multiple sclerosis: a randomized, placebo-controlled trial.
In vitro modeling of central nervous system myelination and remyelination.
Microglia and brain macrophages in the molecular age: from origin to neuropsychiatric disease.
Neuromyelitis optica.
Quadrivalent HPV vaccination and risk of multiple sclerosis and other demyelinating diseases of the central nervous system.
Long-term clinical and magnetic resonance imaging outcomes from patients treated with teriflunomide: Results from a phase 2 extension study.
Sodium accumulation is associated with disability and a progressive course in multiple sclerosis.
Siponimod (BAF312) for the treatment of secondary progressive multiple sclerosis: Design of the phase 3 EXPAND trial.
The immune modulator FTY720 targets sphingosine 1-phosphate receptors.
A randomized trial of high-dose vitamin D2 in relapsing-remitting multiple sclerosis.
Autoimmune myelopathies.
Vitamin D status predicts new brain magnetic resonance imaging activity in multiple sclerosis.
Changes in JC Virus-Specific T Cell Responses during Natalizumab Treatment and in Natalizumab-Associated Progressive Multifocal Leukoencephalopathy.
Validity and reliability of VO2-max measurements in persons with multiple sclerosis.
Opposing Effects of Membrane-Anchored CX3CL1 on Amyloid and Tau Pathologies via the p38 MAPK Pathway.
Time limited immunomodulatory functions of transplanted neural precursor cells.
Safety Study of GNbAC1 in Multiple Sclerosis Patients
Amiloride Clinical Trial In Optic Neuritis (ACTION)
The Impact of Lesion In-Painting and Registration Methods on Voxel-Based Morphometry in Detecting Regional Cerebral Gray Matter Atrophy in Multiple Sclerosis.
Tumefactive multiple sclerosis requiring emergent biopsy and histological investigation to confirm the diagnosis: a case report.
Oral therapies for multiple sclerosis: a review of agents in phase III development or recently approved.
Accelerated and enhanced effect of CCR5-transduced bone marrow neural stem cells on autoimmune encephalomyelitis.
Pages
« first
‹ previous
…
144
145
146
147
148
149
150
151
152
…
next ›
last »